Signal Transduction and Targeted Therapy

Content-Length: 202747 | pFad | http://www.nature.com/sigtrans/

ma=86400 Signal Transduction and Targeted Therapy

feature article

Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial

Jiayong Liu
Xuan Wang
Lu Si

Article 22 November 2024

Featured

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Xuhua Duan
Hao Li
Xinwei Han
ArticleOpen Access13 Nov 2024
Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors

Chaojie Zhu
Chao Liu
Hongjun Li
ArticleOpen Access22 Nov 2024
First-line benmelstobart plus anlotinib and chemotherapy in advanced or metastatic/recurrent esophageal squamous cell carcinoma: a multi-center phase 2 study

Ning Li
Jin Xia
Suxia Luo
ArticleOpen Access08 Nov 2024
Targeted protein degradation: advances in drug discovery and clinical practice

Guangcai Zhong
Xiaoyu Chang
Xiangxiang Zhou
Review ArticleOpen Access06 Nov 2024

Announcements

Behind the Paper

In these Behind the Paper posts, our authors share the real stories behind the latest research papers, from conception to publication, the highs and the lows.

Browse articles

Advancing type 1 diabetes therapy: autologous islet transplant breakthrough

Ram Abou Zaki
Assam El-Osta
Research HighlightOpen Access23 Dec 2024
A predictive language model for SARS-CoV-2 evolution

Enhao Ma
Xuan Guo
Gong Cheng
ArticleOpen Access23 Dec 2024
Chemical inducers of proximity: precision tools for apoptosis in transcriptional regulation

Kai Huang
Research HighlightOpen Access20 Dec 2024
A phase 2 pilot study of umbilical cord blood infusion as an adjuvant consolidation therapy in elderly patients with acute myeloid leukemia

Jinzeng Wang
Xiaoyang Li
Ruibao Ren
ArticleOpen Access20 Dec 2024
Macrophages promote pre-metastatic niche formation of breast cancer through aryl hydrocarbon receptor activity

Xu Jiang
Jiaqi Wang
Ying Wang
ArticleOpen Access18 Dec 2024
Patient-reported outcomes of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer patients (CHART): a randomized, phase 3 study

Hongkai Wang
Shusuan Jiang
Dingwei Ye
ArticleOpen Access18 Dec 2024
Advances in calcium-sensing receptor modulation: biased signaling and therapeutic potential

Luisa Uhlmann
Ulf Wagner
Research HighlightOpen Access16 Dec 2024
Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432)

Xinghao Ai
Bo Jia
Shun Lu
ArticleOpen Access16 Dec 2024
Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer

Miao-Zhen Qiu
Yuxian Bai
Hui-Yan Luo
ArticleOpen Access16 Dec 2024

Trending - Altmetric

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

Search

Advanced search

Quick links